Prediction of the deficit syndrome from initial deficit symptoms in the early course of schizophrenia

被引:25
作者
Subotnik, KL
Nuechterlein, KH
Ventura, J
Green, MF
Hwang, SS
机构
[1] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA
关键词
Proxy for the Deficit Syndrome; negative symptoms; withdrawal-retardation; longitudinal assessment; schizophrenia; first episode;
D O I
10.1016/S0165-1781(98)00052-3
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The Proxy for the Deficit Syndrome (PDS) was used with longitudinal symptom assessment data to identify recent-onset schizophrenia patients with the deficit syndrome. We evaluated the stability of deficit symptoms using repeated assessments. Symptom ratings were examined at an initial point of outpatient stabilization on antipsychotic medication as well as prospectively over the subsequent 12 months of outpatient treatment and assessment in 83 recent-onset schizophrenia patients. The vast majority of patients who were classified as non-deficit at the cross-sectional baseline assessment continued to remain non-deficit throughout the first year of treatment. However, patients classified as deficit at baseline did not consistently remain classified as showing deficit syndrome during the follow-through period. Thus, the presence of deficit symptoms detected in a single cross-sectional rating may be an inaccurate way to rate the deficit syndrome, yielding excessive false positives. Our use of longitudinal data allowed the stability criterion of the deficit syndrome to be evaluated using the PDS. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 50 条
  • [31] Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments
    Martinez, Anton L.
    Brea, Jose
    Rico, Sara
    de los Frailes, Maria Teresa
    Loza, Maria Isabel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [32] ROI-based analysis of diffusion indices in healthy subjects and subjects with deficit or non-deficit syndrome schizophrenia
    Turk, Yasar
    Devecioglu, Ismail
    Kuskun, Atakan
    Oge, Cem
    Beyazyuz, Elmas
    Albayrak, Yakup
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2023, 336
  • [33] Impaired facial affect labeling and discrimination in patients with deficit syndrome schizophrenia
    Strauss, Gregory P.
    Jetha, Shaida S.
    Ross, Sylvia A.
    Duke, Lisa A.
    Allen, Daniel N.
    SCHIZOPHRENIA RESEARCH, 2010, 118 (1-3) : 146 - 153
  • [34] Cognitive Insight and Its Relationship With Symptoms in Deficit and Nondeficit Schizophrenia
    Ekinci, Okan
    Albayrak, Yakup
    Ekinci, Asli
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2012, 200 (01) : 44 - 50
  • [35] Borna disease virus antibodies and the deficit syndrome of schizophrenia
    Waltrip, RW
    Buchanan, RW
    William, TC
    Kirkpatrick, B
    Summerfelt, A
    Breier, A
    Rubin, SA
    Carbone, KM
    SCHIZOPHRENIA RESEARCH, 1997, 23 (03) : 253 - 257
  • [36] How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease-related negative symptoms in schizophrenia
    Barnes, TRE
    McPhillips, MA
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 : 115 - 121
  • [37] Neurocognitive, social, and emotional dysfunction in deficit syndrome schizophrenia
    Horan, WP
    Blanchard, JJ
    SCHIZOPHRENIA RESEARCH, 2003, 65 (2-3) : 125 - 137
  • [38] Tolerance to neuroleptics, deficit syndrome and cognitive functions, in schizophrenia
    Kahn, JP
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1996, 22 : 49 - 54
  • [39] Olfactory Hedonic Judgment in Patients With Deficit Syndrome Schizophrenia
    Strauss, Gregory P.
    Allen, Daniel N.
    Ross, Sylvia A.
    Duke, Lisa A.
    Schwartz, Jason
    SCHIZOPHRENIA BULLETIN, 2010, 36 (04) : 860 - 868
  • [40] Impaired sensorimotor gating in schizophrenia with deficit and with nondeficit syndrome
    Ludewig, K
    Vollenweider, FX
    SWISS MEDICAL WEEKLY, 2002, 132 (13-14) : 159 - 165